Quantcast

Latest Allotransplantation Stories

2014-05-27 16:26:07

Company Provides Insight into 2015 Revenue Opportunities MARIETTA, Ga., May 27, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its revised guidance for the second quarter of 2014 and full year 2014, and provided insight onto various factors influencing the Company's revenue opportunities in 2015 and beyond. Parker H....

2014-05-20 16:23:32

MARIETTA, Ga., May 20, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today it has declined to participate in the adjudication of an advertising challenge filed with the National Advertising Division of the Council of Better Business Bureaus (NAD). The NAD administers a self-regulation program designed to ensure the...

2014-05-09 20:22:24

Gase, a NASCAR Nationwide Series Driver, raises awareness about organ, eye and tissue donation by driving the Donate Life® racecar CENTENNIAL, Colo., May 9, 2014 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, hosted Joey Gase, a NASCAR Nationwide Series Driver and donor son, with the Limb Preservation...

2014-04-29 16:32:03

Company Amends its Patent Infringement Lawsuit to Include Two Additional Patents MARIETTA, Ga., April 29, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of four newly issued patents related to the Company's tissue allografts derived from the placenta. On April 22, 2014, the U.S. Patent and...

2014-04-28 12:31:29

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S Orthopedic Biomaterials Markethttp://www.reportbuyer.com/pharma_healthcare/biotechnology/u_s_orthopedic_biomaterials_market.html In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion. This total comprises eight different market segments.The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical...

2014-04-25 23:09:12

The breakthrough Pinhole procedure is used to treat gingival recession and it often eliminates the need for cutting, stitching, and downtime of traditional gingival grafting. This procedure is a sophisticated new technique that offers patients an alternative to connective tissue graft or allograft procedures. Detroit, MI (PRWEB) April 25, 2014 Gingival recession is a common yet serious condition in which the gums pull back from the normal, healthy gumline. Gum recession can cause tooth...

2014-04-23 12:29:59

WEST CONSHOHOCKEN, Pa., April 23, 2014 /PRNewswire/ -- Liventa Bioscience, (formerly AFCell Medical), one of the leading innovators of allograft implants from human amniotic membrane in the United States, has received notice that MiMedx Group, Inc. (MDXG), filed a patent infringement lawsuit against it, its partner in the wound care market, Medline and Liventa's processing partner, Musculoskeletal Transplant Foundation, Inc. (MTF). Robin R. Young, CEO of Liventa Bioscience, said,...

2014-04-22 08:33:34

MARIETTA, Ga., April 22, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc. ("Liventa"), Medline Industries, Inc. ("Medline") and Musculoskeletal Transplant Foundation, Inc. ("MTF") for permanent injunctive relief and unspecified...

2014-04-22 04:21:26

Off-the shelf biologic medical device is now approved and poised for introduction in the EU for use in certain anterior cruciate ligament (ACL) knee surgeries SAN ANTONIO, Texas, April 22, 2014 /PRNewswire/ -- Aperion Biologics, Inc. was granted the CE Mark approval for its lead product, the Z-Lig(TM) ACLR device, to be used by surgeons in the European Union and other territories that accept the CE Mark. The Z-Lig(TM) is the first engineered biologic device for treatment of revision...

2014-04-18 16:22:59

Company recognized for commitment to process excellence CENTENNIAL, Colo., April 18, 2014 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, has been awarded the Rocky Mountain Performance Excellence (RMPEx) Timberline Performance Award during a ceremony held today. The award recognizes AlloSource's...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related